VAN BUREN TOWNSHIP, Mich., Oct. 17, 2014 /PRNewswire/ -- About 230 Visteon Corporation employees participated in a 5K run/walk at the company's corporate offices and innovation center in Van Buren Township on Oct. 16 – raising nearly $17,000 for the Walt Breast Cancer Indigent Clinical Care Fund at the Barbara Ann Karmanos Cancer Institute in Detroit.
Employees donated to enter the "Striding to End Breast Cancer" run/walk and wore T-shirts with the handwritten names of friends or loved ones who have been impacted by breast cancer. Company matching funds contributed to the total amount raised.
Established for uninsured or underinsured breast cancer patients and their families, the Walt Breast Cancer Indigent Clinical Care Fund provides for non-medical supportive needs such as rent, utilities and family needs.
View high-resolution images of the event at http://visteon.com/media/multimedia/index.html
About Visteon
Visteon is a global automotive supplier delivering value for vehicle manufacturers and shareholders through two high-growth core businesses: automotive cockpit electronics and thermal management. Visteon owns 70 percent of Halla Visteon Climate Control Corp., the world's second largest provider of vehicle thermal management solutions. Visteon designs, engineers and manufactures innovative components and systems for virtually every vehicle manufacturer worldwide. With corporate offices in Van Buren Township, Mich. (U.S.); Shanghai, China; and Chelmsford, UK; Visteon has facilities in 31 countries and employs about 29,000 people. Visteon had sales of $7.4 billion in 2013. Learn more at www.visteon.com.
Follow Visteon:
https://www.facebook.com/VisteonCorporation
www.twitter.com/visteon
www.youtube.com/visteon
http://blog.visteon.com
www.google.com/+visteon
www.linkedin.com/company/visteon
Logo- http://photos.prnewswire.com/prnh/20001201/DEF008LOGO
SOURCE Visteon Corporation
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article